TY  - JOUR
AU  - Abril-Molina, Ana
AU  - Gómez-Luque, Jose M
AU  - Perin, Francesca
AU  - Esteban-Molina, María
AU  - Ferreiro-Marzal, Andrea
AU  - Fernandez-Guerrero, Cristina
AU  - Ocete-Hita, Esther
PY  - 2020
DO  - 10.1007/s40268-020-00332-1
UR  - http://hdl.handle.net/10668/16856
T2  - Drugs in R&D
AB  - The aim was to test the hypothesis that preoperative infusion of levosimendan would decrease patients' cardiac biomarker profiles during the immediate postoperative stage (troponin I and B-type natriuretic peptide levels) more efficiently than placebo...
LA  - en
KW  - Biomarkers
KW  - Cardiopulmonary Bypass
KW  - Cardiotonic Agents
KW  - Child, Preschool
KW  - Double-Blind Method
KW  - Female
KW  - Heart Defects, Congenital
KW  - Heart Injuries
KW  - Hemodynamics
KW  - Humans
KW  - Infant
KW  - Infusions, Intravenous
KW  - Intensive Care Units, Pediatric
KW  - Lactic Acid
KW  - Length of Stay
KW  - Male
KW  - Natriuretic Peptide, Brain
KW  - Oxygen
KW  - Postoperative Complications
KW  - Preoperative Care
KW  - Respiration, Artificial
KW  - Simendan
KW  - Survival Rate
KW  - Troponin I
TI  - Effect of Preoperative Infusion of Levosimendan on Biomarkers of Myocardial Injury and Haemodynamics After Paediatric Cardiac Surgery: A Randomised Controlled Trial.
TY  - research article
VL  - 21
ER  -